Study supports safety of COVID-19 vaccines in people with a history of severe allergic reactions

COVID-19 vaccine
Credit: Pixabay/CC0 Public Domain

New research addresses ongoing concerns regarding risks of allergic reactions after receiving mRNA COVID-19 vaccines, particularly for individuals with a history of severe allergic reactions. The JAMA Network Open study of employee vaccinations within the Mass General Brigham health care system revealed that although people with such a history reported more allergic symptoms after vaccination, nearly all of them were able to become fully vaccinated.

In the study of 52,998 health care employees, 474 (0.9%) reported a history of severe to medications, vaccines or allergens. Survey results showed that 11.6% of employees with this history reported allergic reactions after receiving dose 1 or 2 of a COVID-19 mRNA vaccine, compared with 4.7% of employees without this history. High-risk history was associated with a 2.5-times increased relative risk of allergic reactions, with the highest risks for hives and angioedema. However, despite these symptoms, 5,1706 employees (97.6%) received 2 doses of an mRNA COVID-19 vaccine.

"The results of this study can help guide expectations for patients with high-risk allergy histories. Symptoms such as hives and swelling may occur, particularly with the first vaccine dose, but most reported did not impede completion of the two-dose mRNA vaccine series," says lead author Lily Li, MD, allergy faculty in the Division of Allergy and Clinical Immunology at Brigham and Women's Hospital.

The findings provide reassurance regarding the safety of mRNA COVID-19 vaccination in individuals regardless of allergy history. "We hope these data will help inform ongoing conversations with patients who are hesitant to receive COVID-19 vaccination due to allergy concerns," says senior author author Kimberly G. Blumenthal, MD, MSc, co-director of the Clinical Epidemiology Program within Massachusetts General Hospital's Division of Rheumatology, Allergy and Immunology. "At our institutions, nearly all individuals with and without a history of high-risk allergy were able to complete the two-dose series."

Co-authors include Lacey B. Robinson, MD, MPH; Rajesh Patel, MD, MPH; Adam Landman, MD; Xiaoqing Fu, MS; Erica S. Shenoy, MD, Ph.D.; Dean M. Hashimoto, MD; Aleena Banerji, MD; Paige G. Wickner, MD, MPH; Upeka Samarakoon, MS, Ph.D., MPH; Christian M. Mancini, BS; and Yuqing Zhang, Dsc.


Explore further

Second COVID-19 mRNA vaccine dose found safe following allergic reactions to first dose

More information: Association of Self-reported High-Risk Allergy History With Allergy Symptoms After COVID-19 Vaccination, JAMA Network Open (2021). DOI: 10.1001/jamanetworkopen.2021.31034
Journal information: JAMA Network Open

Citation: Study supports safety of COVID-19 vaccines in people with a history of severe allergic reactions (2021, October 26) retrieved 2 December 2021 from https://medicalxpress.com/news/2021-10-safety-covid-vaccines-people-history.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
1 shares

Feedback to editors